MICHELLE NGUYEN: Open Payments
NPI 1225466311 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 66 payments from 18 companies in 2025. Trend: 2023 $752 · 2024 $1,450 · 2025 $1,617
Food & beverage: $1,617
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $472 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $252 |
| Novo Nordisk Inc | 8 | $166 |
| Amgen Inc. | 11 | $144 |
| ABBVIE INC. | 5 | $108 |
| PFIZER INC. | 4 | $103 |
| Exact Sciences Corporation | 5 | $98 |
| Lilly USA, LLC | 3 | $49 |
| Abbott Laboratories | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $35 |
Products named: AIRSUPRA, Kerendia, OTEZLA, BREZTRI, Cologuard Collection Kit, Wegovy, PREVNAR 20, VRAYLAR.
Industry payments across TX — which companies pay providers there.
